Stay updated on Immune Response in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Immune Response in NSCLC Clinical Trial page.

Latest updates to the Immune Response in NSCLC Clinical Trial page
- Check5 days agoChange DetectedA sitewide banner announces NIH website updates and says federal agencies are transitioning from the term “Artificial Intelligence” to “Super Intelligence.”SummaryDifference1%

- Check12 days agoChange DetectedThe ClinicalTrials.gov error page footer updates its revision identifier from v3.7.1 to v3.7.2, while the study record remains inaccessible.SummaryDifference0.2%

- Check19 days agoChange DetectedThe ClinicalTrials.gov error page displays an updated site revision number in its footer.SummaryDifference0.2%

- Check40 days agoChange DetectedThe page now displays a 403 Forbidden error, blocking access to the study record. This represents an access restriction rather than an update to the page content.SummaryDifference21%

- Check61 days agoChange DetectedThe site's revision tag updated from v3.6.5 to v3.6.6, signaling a routine update. There are no visible changes to the study details or page content.SummaryDifference0.1%

- Check75 days agoChange DetectedThe page now presents direct access to the official documents (Informed Consent Form, Study Protocol and Statistical Analysis Plan). It also includes related indexing terms and document categories to improve navigation and transparency around the study documents.SummaryDifference66%

Stay in the know with updates to Immune Response in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immune Response in NSCLC Clinical Trial page.